Red day on Friday for Acura Pharmaceuticals
(Updated on Nov 26, 2021)
Sell candidate since 2021-11-26 PDF
No changes to the price of Acura Pharmaceuticals stock on the last trading day (Friday, 26th Nov 2021). During the day the stock fluctuated 0% from a day low at $0.52 to a day high of $0.52. The price has been going up and down for this period, and there has been a -6.73% loss for the last 2 weeks.
The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Acura Pharmaceuticals stock with a 90% probability to be traded between $0.48 and $0.58 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Signals & Forecast
There are few to no technical positive signals at the moment. The Acura Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.53 and $0.55. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 23, 2021, and so far it has fallen -11.11%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss
Acura Pharmaceuticals finds support from accumulated volume at $0.52 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had a daily average volatility of 4.72%.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is Acura Pharmaceuticals stock A Buy?
Acura Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.612
Predicted Opening Price for Acura Pharmaceuticals of Monday, November 29, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price November 29, 2021||Current price|
Remember To Visit Our YouTube Channel
ACUR Insider Trading
|Jun 09, 2021||Sell||6 877 500||Abuse Deterrent Pharma, Llc||Convertible Promissory Note|
|Jun 09, 2021||Buy||42 984 375||Abuse Deterrent Pharma, Llc||Common Stock|
|Jun 09, 2021||Buy||42 984 375||Schutte John||Common Stock|
|May 25, 2021||Buy||66 666||Thangaraj Immanuel||Restricted Stock Units (2021 Plan)|
|May 25, 2021||Buy||66 666||Skelly William G||Restricted Stock Units (2021 Plan)|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.